US 10,610,327

Application 15/261,660 · Granted Apr 7, 2020

Apparatus and method for puncturing the epidermis with controlled fluid delivery

Estimated expiration

September 1, 2037

10y 286d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Sep 9, 2016
+ 20 years
Sep 9, 2036
PTA +357d
Sep 1, 2037
No TD
—
Final
Sep 1, 2037

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
September 9, 2016
Earliest effective filing
September 9, 2016
Issue date
April 7, 2020
PTA
+357 days
Base expiry (before PTA)
September 9, 2036

September 9, 2016 + 20 years = September 9, 2036 + 357 PTA days = September 1, 2037

  • PRO62/216,206 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/261,660 · US 10,610,327

PatentReply compiles the prosecution history behind US 10,610,327: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US10610327

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.